Charles T. Esmon

Charles T. Esmon

Auto-generated profile, based on publicly available information

Charles T. Esmon

Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2009 in Nature Medicine
Verified
Journal Article
Open access
PDF file
JXJun Xu
Jun Xu
XZXiaomei Zhang
Xiaomei Zhang
RPRosana Pelayo
Rosana Pelayo
MMMarc Monestier
Marc Monestier
CAConcetta T Ammollo
Concetta T Ammollo
CECharles T Esmon
Charles T Esmon
Extracellular histones released in response to inflammatory challenge contribute to organ failure and death during sepsis. Histone-specific antibodies and activated protein C had beneficial effects in animal models of sepsis, pointing to extracellular histones as therapeutics targets for sepsis and other inflammatory conditions ( pages 1245–1246 ). Hyperinflammatory responses can lead to a variety of diseases, including sepsis1. We now report that extracellular histones released in response to inflammatory challenge contribute to endothelial dysfunction, organ failure and death during sepsis. They can be targeted pharmacologically by antibody to histone or by activated protein C (APC). Antibody to histone reduced the mortality of mice in lipopolysaccharide (LPS), tumor necrosis factor (TNF) or cecal ligation and puncture models of sepsis. Extracellular histones are cytotoxic toward endothelium in vitro and are lethal in mice. In vivo, histone administration resulted in neutrophil margination, vacuolated endothelium, intra-alveolar hemorrhage and macro- and microvascular thrombosis. We detected histone in the circulation of baboons challenged with Escherichia coli, and the increase in histone levels was accompanied by the onset of renal dysfunction. APC cleaves histones and reduces their cytotoxicity. Co-infusion of APC with E. coli in baboons or histones in mice prevented lethality. Blockade of protein C activation exacerbated sublethal LPS challenge into lethality, which was reversed by treatment with antibody to histone. We conclude that extracellular histones are potential molecular targets for therapeutics for sepsis and other inflammatory diseases.

18 August 2011 in Blood
Verified
Journal Article
Open access
PDF file
FSFabrizio Semeraro
Fabrizio Semeraro
CAConcetta T. Ammollo
Concetta T. Ammollo
James H. MorrisseyJames H. Morrissey
James H. Morrissey
GDGeorge L. Dale
George L. Dale
PFPaul Friese
Paul Friese
CECharles T. Esmon
Charles T. Esmon
The release of histones from dying cells is associated with microvascular thrombosis and, because histones activate platelets, this could represent a possible pathogenic mechanism. In the present study, we assessed the influence of histones on the procoagulant potential of human platelets in platelet-rich plasma (PRP) and in purified systems. Histones dose-dependently enhanced thrombin generation in PRP in the absence of any trigger, as evaluated by calibrated automated thrombinography regardless of whether the contact phase was inhibited. Activation of coagulation required the presence of fully activatable platelets and was not ascribable to platelet tissue factor, whereas targeting polyphosphate with phosphatase reduced thrombin generation even when factor XII (FXII) was blocked or absent. In the presence of histones, purified polyphosphate was able to induce thrombin generation in plasma independently of FXII. In purified systems, histones induced platelet aggregation; P-selectin, phosphatidylserine, and FV/Va expression; and prothrombinase activity. Blocking platelet TLR2 and TLR4 with mAbs reduced the percentage of activated platelets and lowered the amount of thrombin generated in PRP. These data show that histone-activated platelets possess a procoagulant phenotype that drives plasma thrombin generation and suggest that TLR2 and TLR4 mediate the activation process.

1 September 2011 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JXJun Xu
Jun Xu
XZXiaomei Zhang
Xiaomei Zhang
MMMarc Monestier
Marc Monestier
NENaomi L. Esmon
Naomi L. Esmon
CECharles T. Esmon
Charles T. Esmon
We previously reported that extracellular histones are major mediators of death in sepsis. Infusion of extracellular histones leads to increased cytokine levels. Histones activate TLR2 and TLR4 in a process that is enhanced by binding to DNA. Activation of TLR4 is responsible for the histone-dependent increase in cytokine levels. To study the impact of histone release on pathology we used two models: a Con A-triggered activation of T cells to mimic sterile inflammation, and acetaminophen to model drug-induced tissue toxicity. Histones were released in both models and anti-histone Abs were protective. TLR2- or TLR4-null mice were also protected. These studies imply that histone release contributes to death in inflammatory injury and in chemical-induced cellular injury, both of which are mediated in part through the TLRs.

28 June 2011 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
CAC. T. Ammollo
C. T. Ammollo
FSF. Semeraro
F. Semeraro
JXJ. Xu
J. Xu
NEN. L. Esmon
N. L. Esmon
CEC. T. Esmon
C. T. Esmon

22 July 2011 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
CEC. T. Esmon
C. T. Esmon
JXJ. Xu
J. Xu
FLF. Lupu
F. Lupu

1 January 2010 in Hamostaseologie
Verified
Journal Article
Closed access
PDF file
JXJ. Xu
J. Xu
FLF. Lupu
F. Lupu
CEC. T. Esmon
C. T. Esmon
Summary: Inflammation drives arterial, venous and microvascular thrombosis. Chronic inflammation contributes to arterial thrombotic complications, whereas acute inflammation drives venous thrombosis and microvascular thrombosis. Mechanistically, inflammation modulates thrombotic responses by upregulating procoagulants, downregulating anticoagulants and suppressing fibrinolysis. The inflammatory response can also result in cell apoptosis or necrosis. Products released from the dead cells, particularly histones, propagate further inflammation, tissue death and organ failure.Inhibition of histone mediated cytotoxicity appears to be a new mechanism for protecting against this deadly cascade.